Skip to Content

124 (Pantoprazole sodium delayed release 40 mg)

Pill imprint 124 has been identified as Pantoprazole sodium delayed release 40 mg.

Pantoprazole is used in the treatment of gerd; barrett's esophagus; dumping syndrome; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Pantoprazole 40 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Pantoprazole sodium delayed release 40 mg 124
Pantoprazole sodium delayed release 40 mg 124  Front
Pantoprazole sodium delayed release 40 mg 124  Back
Pantoprazole sodium delayed release
40 mg
Prescription only
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
41616-0580 Sun Pharmaceutical Industries Ltd
68084-0283 Amerisource Health Services
54569-6062 A-S Medication Solutions, LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.